BIOMARIN PHARMACEUTICAL INC Buildings and Improvements, Gross
BIOMARIN PHARMACEUTICAL INC (BMRN) had Buildings and Improvements, Gross of $159.13 million as of 2013-12-31, per its 10-K filed 2014-02-26.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:BuildingsAndImprovementsGross · last filed 2014-02-26
- 2013-12-31: Buildings and Improvements, Gross $159.13M.
- 2013-09-30: Buildings and Improvements, Gross $154.48M.
- 2013-06-30: Buildings and Improvements, Gross $147.00M.
- 2013-03-31: Buildings and Improvements, Gross $146.55M.
| Period end | Buildings and Improvements, Gross |
|---|---|
| 2013-12-31 | $159.13M 10-K · filed 2014-02-26 |
| 2013-09-30 | $154.48M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $147.00M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $146.55M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $144.70M 10-K · filed 2014-02-26 |
| 2012-09-30 | $143.77M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $143.02M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $142.71M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $141.48M 10-K · filed 2013-02-26 |
| 2010-12-31 | $138.03M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |